Genomic Decoding of Intrahepatic Cholangiocarcinoma Reveals Therapeutic Opportunities

被引：16
作者：
Andersen, Jesper B. [1 ]
Thorgeirsson, Snorri S. [1 ]
机构：
[1] NIH, Expt Carcinogenesis Lab, Bethesda, MD 20892 USA
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 04期
关键词：
MOLECULAR ANALYSIS; GENE; RECURRENCE; CARCINOMA;
D O I：
10.1053/j.gastro.2013.02.018
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：687 / 690
页数：4
相关论文
共 25 条
  • [1] Genetic profiling of intrahepatic cholangiocarcinoma
    Andersen, Jesper B.
    Thorgeirsson, Snorri S.
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2012, 28 (03) : 266 - 272
  • [2] Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
    Andersen, Jesper B.
    Spee, Bart
    Blechacz, Boris R.
    Avital, Itzhak
    Komuta, Mina
    Barbour, Andrew
    Conner, Elizabeth A.
    Gillen, Matthew C.
    Roskams, Tania
    Roberts, Lewis R.
    Factor, Valentina M.
    Thorgeirsson, Snorri S.
    [J]. GASTROENTEROLOGY, 2012, 142 (04) : 1021 - U552
  • [3] An Integrated Genomic and Epigenomic Approach Predicts Therapeutic Response to Zebularine in Human Liver Cancer
    Andersen, Jesper B.
    Factor, Valentina M.
    Marquardt, Jens U.
    Raggi, Chiara
    Lee, Yun-Han
    Seo, Daekwan
    Conner, Elizabeth A.
    Thorgeirsson, Snorri S.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (54)
  • [4] Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development
    Avruch, J.
    Zhou, D.
    Fitamant, J.
    Bardeesy, N.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 104 (01) : 24 - 32
  • [5] Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
    Bekaii-Saab, Tanios
    Phelps, Mitch A.
    Li, Xiaobai
    Saji, Motoyasu
    Goff, Laura
    Kauh, John Sae Wook
    O'Neil, Bert H.
    Balsom, Stephanie
    Balint, Catherine
    Liersemann, Ryan
    Vasko, Vasily V.
    Bloomston, Mark
    Marsh, William
    Doyle, L. Austin
    Ellison, Gilian
    Grever, Michael
    Ringel, Matthew D.
    Villalona-Calero, Miguel A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) : 2357 - 2363
  • [6] Clinical diagnosis and staging of cholangiocarcinoma
    Blechacz, Boris
    Komuta, Mina
    Roskams, Tania
    Gores, Gregory J.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (09) : 512 - 522
  • [7] Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
    Borger, Darrell R.
    Tanabe, Kenneth K.
    Fan, Kenneth C.
    Lopez, Hector U.
    Fantin, Valeria R.
    Straley, Kimberly S.
    Schenkein, David P.
    Hezel, Aram F.
    Ancukiewicz, Marek
    Liebman, Hannah M.
    Kwak, Eunice L.
    Clark, Jeffrey W.
    Ryan, David P.
    Deshpande, Vikram
    Dias-Santagata, Dora
    Ellisen, Leif W.
    Zhu, Andrew X.
    Iafrate, A. John
    [J]. ONCOLOGIST, 2012, 17 (01) : 72 - 79
  • [8] Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas
    Cazals-Hatem, D
    Rebouissou, S
    Bioulac-Sage, P
    Bluteau, O
    Blanché, H
    Franco, D
    Monges, G
    Belghiti, J
    Cunha, AS
    Laurent-Puig, P
    Degott, C
    Zucman-Rossi, J
    [J]. JOURNAL OF HEPATOLOGY, 2004, 41 (02) : 292 - 298
  • [9] Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
    El-Serag, Hashem B.
    Rudolph, Lenhard
    [J]. GASTROENTEROLOGY, 2007, 132 (07) : 2557 - 2576
  • [10] Genetic classification of combined hepatocellular-cholangiocarcinoma
    Fujii, H
    Zhu, XG
    Matsumoto, T
    Inagaki, M
    Tokusashi, Y
    Miyokawa, N
    Fukusato, T
    Uekusa, T
    Takagaki, T
    Kadowaki, N
    Shirai, T
    [J]. HUMAN PATHOLOGY, 2000, 31 (09) : 1011 - 1017
123